Quiver Bioscience
PrivateLast Round
Grant
May 5, 2026
Total Funding Raised
$3.65M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Quiver Bioscience operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was a Strategic round in April 2026.
Quiver Bioscience is a biotechnology company that offers a neuroscience research platform to accelerate the discovery of therapeutics for central nervous system disorders.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Government Contracts
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Quiver Bioscience Comparables
Compare Quiver Bioscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AcuraStem | 86% | |
| 28bio | 84% | |
| Unravel Biosciences | 83% |
For institutional investors. Book with your work email.
Quiver Bioscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 5, 2026 | ||||
| Strategic | Apr 13, 2026 | ||||
| Grant | Sep 18, 2025 | ||||
| Grant | Jul 2, 2025 | ||||
| Grant | Jul 1, 2025 | ||||
Grant | Mar 19, 2025 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Quiver Bioscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| CURE Epilepsy | Grant |
| NIH Helping to End Addiction Long-term (HEAL) Initiative | Grant |
| NIH RADx | Grant |
| FRAXA Research Foundation | Grant |
| National Institute of Neurological Disorders and Stroke | Grant |
| Exponential Capital Management | M&A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 67% MoM.
- May 16, 2026
Monthly visitors increased 58% MoM.
For institutional investors. Book with your work email.
Quiver Bioscience Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Quiver Bioscience's valuation, stock price, and market status.
Is Quiver Bioscience a public or private company?
Quiver Bioscience is a private company.
What is the current stock price of Quiver Bioscience?
Quiver Bioscience is a private company, so its shares have no public market price. Caplight tracks Quiver Bioscience's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Quiver Bioscience worth (valuation)?
Valuation information for Quiver Bioscience is not publicly available.
Can I buy Quiver Bioscience stock?
Quiver Bioscience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Quiver Bioscience's last funding round?
Quiver Bioscience's most recent funding round was Grant on May 5, 2026.
Who are the main investors in Quiver Bioscience?
Key investors in Quiver Bioscience include Exponential Capital Management.
Will Quiver Bioscience IPO soon?
No public IPO plans have been announced for Quiver Bioscience.
How can I track Quiver Bioscience secondary market activity?
Caplight tracks bids, offers, and trades in Quiver Bioscience's shares on secondary markets.